Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Rocas
- Ownership
- Private
- Development stage
- Other
01
Overview
Rocas Therapeutics is an early-stage biotechnology company focused on the development of novel small molecule therapies for the treatment of cancer. The company leverages its proprietary drug discovery expertise to identify and optimize candidates targeting critical pathways in tumor progression and survival. Rocas aims to address significant unmet medical needs in oncology by developing precision medicines that offer improved efficacy and safety profiles compared to current standards of care. Currently, the company's programs are in the pre-clinical stage, with a focus on advancing lead candidates toward IND-enabling studies.
- Therapeutic areas
- Oncology
- Modalities
- Small molecule
- Industry
- Biotech
Beyond the preview
Go deeper on Rocas.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Rocas.